Top Markets
Coin of the day
NeoCore Technology Co., Ltd. NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd.

4131
Rang in Aktien #26461
NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture,... NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture, and distribution of biochips and advanced rapid nucleic acid hybridization devices. Their extensive product range features systems designed for food safety screening, human diagnostic arrays, agricultural analysis, and specific food examination arrays, in addition to a variety of laboratory instruments and DNA kits. The company further provides a suite of services, encompassing laboratory planning, design, and additional specialized support. Beyond its core biotech operations, NeoCore also participates in the wholesale and retail market for contact lenses. The firm, which was established in 1987 and is based in Tainan, Taiwan, underwent a name change in July 2023, transitioning from its former identity as DR. Chip Biotechnology Incorporation to its current name.
Aktienkurs
$1.02
Marktkapitalisierung
$40.42M
Veränderung (1 Tag)
-1.08%
Veränderung (1 Jahr)
-10.53%
Land
TW
Handel NeoCore Technology Co., Ltd. (4131)

Kategorie

EPS für NeoCore Technology Co., Ltd. (4131)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von NeoCore Technology Co., Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von NeoCore Technology Co., Ltd. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -
US
$27.74 -
NL
$2.98 -
AU
$-7.98 -
US
- -
CH